Liquid biopsy assays are diagnostic tests that analyze genetic material, proteins, or other biomarkers found in bodily fluids, such as blood, urine, or saliva, to detect and monitor various diseases, including cancer. These emerging assays offer several advantages over traditional tissue biopsy procedures, such as being less invasive and allowing for more frequent monitoring of disease progression.
The goal of this Research Topic is to explore the intersection between clinical and molecular liquid biopsy research and health care disparities and access research. The development of self-collected liquid biopsy assays has the potential to reduce disparities in healthcare outcomes by providing more accurate and timely diagnoses, especially for individuals who may be hesitant to undergo invasive procedures or have barriers to healthcare access. The recent advances in self-collection-based assays have the potential to revolutionize healthcare access and equity, and this Research Topic aims to promote ongoing research to explore the benefits and challenges to advancing these new tests to efficiently decrease barriers across populations.
We welcome contributions on the scientific, ethical, social, and economic implications of implementing liquid biopsy tests in clinical practice for early detection and disease monitoring. The scope of this Research Topic includes but is not limited to:
(1) The clinical utility of liquid biopsy assays in various disease contexts,
(2) The potential benefits and limitations of self-collected liquid biopsy assays,
(3) The impact of liquid biopsy tests on healthcare disparities and access, and
(4) The future directions and challenges in the development and implementation of liquid biopsy tests.
We are interested in Original Research articles, Reviews, and Perspectives that contribute to this topic.
Liquid biopsy assays are diagnostic tests that analyze genetic material, proteins, or other biomarkers found in bodily fluids, such as blood, urine, or saliva, to detect and monitor various diseases, including cancer. These emerging assays offer several advantages over traditional tissue biopsy procedures, such as being less invasive and allowing for more frequent monitoring of disease progression.
The goal of this Research Topic is to explore the intersection between clinical and molecular liquid biopsy research and health care disparities and access research. The development of self-collected liquid biopsy assays has the potential to reduce disparities in healthcare outcomes by providing more accurate and timely diagnoses, especially for individuals who may be hesitant to undergo invasive procedures or have barriers to healthcare access. The recent advances in self-collection-based assays have the potential to revolutionize healthcare access and equity, and this Research Topic aims to promote ongoing research to explore the benefits and challenges to advancing these new tests to efficiently decrease barriers across populations.
We welcome contributions on the scientific, ethical, social, and economic implications of implementing liquid biopsy tests in clinical practice for early detection and disease monitoring. The scope of this Research Topic includes but is not limited to:
(1) The clinical utility of liquid biopsy assays in various disease contexts,
(2) The potential benefits and limitations of self-collected liquid biopsy assays,
(3) The impact of liquid biopsy tests on healthcare disparities and access, and
(4) The future directions and challenges in the development and implementation of liquid biopsy tests.
We are interested in Original Research articles, Reviews, and Perspectives that contribute to this topic.
